Drimva

Edison Scientific

Member of GTM Staff, Strategic Partnerships

$225K–$400K

San Francisco +2 · On-site · Staff · Full-time · Posted Jul 7, 2026

Location
San Francisco
New York
Remote available (U.S. Only)
Experience
10+ years; no alternatives stated.

About the job

Own strategic biopharma commercial relationships from prospecting through enterprise deployment, renewal, and expansion, carrying an individual revenue target.

What you'll do

  • Lead the full commercial cycle for a focused portfolio of strategic biopharma accounts, including account planning, negotiation, close, renewal, and expansion.
  • Partner with scientific, engineering, and product teams to shape use cases, deployments, and measurable value cases for biopharma R&D.
  • Build senior customer relationships and maintain disciplined pipeline management, forecasting, and customer feedback processes.

What they ask for

  • 10+ years of enterprise sales, business development, or strategic account experience, including significant experience selling to pharmaceutical or biotechnology companies.
  • Consistently carried and exceeded multi-million-dollar revenue targets while personally originating and closing complex enterprise agreements.
  • Understand biopharma R&D workflows across discovery, translational research, clinical development, and regulatory submission.
  • Experience navigating large buying committees and requirements involving scientific validation, data governance, security, compliance, procurement, Legal, and Finance.

Nice to have

  • Experience bringing AI, computational, data, or scientific platforms into biopharma R&D organizations.
  • Familiarity with computational biology, cheminformatics, translational science, or AI-enabled drug development.

Pay

Base $225,000 - 275,000 USD (base salary); Total OTE $275,000 - $400,000 USD (total pay)

AI focus

Sell AI scientist agents and related capabilities for biopharma R&D, translating them into scientific, operational, and economic value.

Model-written summary · the original posting is authoritative

First seen Oct 29, 2026 · Last verified Nov 6, 2026 (UTC)